ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Provenge Met Criteria For Approval, Sponsor Says

May 1, 2009

PBS Runs Misleading Lung Screening Claim; Reporter and Subject on Mount Sinai Faculty

October 11, 2013

Upton Heads NIH Effort To Define Prevention

April 21, 1978

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999

In Brief: Patterns Of care Study Leads “Part Tie” Radiotherapists To Drop Out, Sheline Says

July 22, 1977

Mothers’ Smoking, Depression Influences Teen Smoking

May 28, 2010